SGR-3515

N/A

Report date: 2024/06/18 20:00:07
NME

Base Information

Drug NameSGR-3515
Drug Alias NameSGR-3515
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase WEE1 inhibitors
TargetsSerine/threonine-protein kinase WEE1
Therapy Area/IndicationsSolid tumoursGenital Neoplasms, Female
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSchrödinger Inc
China Registration ClassN/A

Develop Information

Active CompaniesSchrödinger Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursGenital Neoplasms, Female
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A